247 related articles for article (PubMed ID: 35000022)
21. Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis.
Nie K; Zhang YX; Nie W; Zhu L; Chen YN; Xiao YX; Liu SY; Yu H
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):84-93. PubMed ID: 30230710
[TBL] [Abstract][Full Text] [Related]
22.
Jung SH; Kwon SY; Min JJ; Bom HS; Ahn SY; Jung SY; Lee SS; Park MR; Yang DH; Ahn JS; Kim HJ; Lee JJ
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):107-115. PubMed ID: 30187105
[TBL] [Abstract][Full Text] [Related]
23.
Peng L; Du B; Cui Y; Luan Q; Li Y; Li X
Clin Lung Cancer; 2022 Nov; 23(7):608-619. PubMed ID: 36089482
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis of
Reinders Folmer EI; von Meijenfeldt GCI; Te Riet Ook Genaamd Scholten RS; van der Laan MJ; Glaudemans AWJM; Slart RHJA; Zeebregts CJ; Saleem BR
J Vasc Surg; 2020 Dec; 72(6):2174-2185.e2. PubMed ID: 32645420
[TBL] [Abstract][Full Text] [Related]
25. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.
Zhu D; Wang Y; Wang L; Chen J; Byanju S; Zhang H; Liao M
Acta Radiol; 2018 Sep; 59(9):1082-1090. PubMed ID: 29256260
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of
Han S; Choi JY
Breast Cancer Res; 2020 Oct; 22(1):119. PubMed ID: 33129348
[TBL] [Abstract][Full Text] [Related]
29. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Alongi P; Caobelli F; Gentile R; Stefano A; Russo G; Albano D; Baldari S; Gilardi MC; Midiri M
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):224-233. PubMed ID: 27565154
[TBL] [Abstract][Full Text] [Related]
30. Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On
Cho HJ; Baek DW; Kim JH; Lee J; Chung YK; Jung SH; Song GY; Ahn SY; Ahn JS; Yang DH; Lee JJ; Kim HJ; Hong CM; Jeong SY; Min JJ; Sohn SK; Moon JH
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):113-120. PubMed ID: 34598908
[TBL] [Abstract][Full Text] [Related]
31. The Role of 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography as Response and Prognosis Predictive Factor of Concurrent Chemoradiotherapy after Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Study.
Šedienė S; Kulakienė I; Rudžianskas V; Ambrazienė R
Medicina (Kaunas); 2018 May; 54(2):. PubMed ID: 30344262
[No Abstract] [Full Text] [Related]
32. Usefulness of
Xian WJ; Feng YL; Wang Y; Yang M; Lu SN
Br J Radiol; 2022 Jan; 95(1129):20210279. PubMed ID: 34813375
[TBL] [Abstract][Full Text] [Related]
33. Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.
Dai N; Liu H; Deng S; Sang S; Wu Y
Technol Cancer Res Treat; 2021; 20():15330338211056478. PubMed ID: 34806464
[No Abstract] [Full Text] [Related]
34. Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials.
Jamet B; Morvan L; Nanni C; Michaud AV; Bailly C; Chauvie S; Moreau P; Touzeau C; Zamagni E; Bodet-Milin C; Kraeber-Bodéré F; Mateus D; Carlier T
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1005-1015. PubMed ID: 33006656
[TBL] [Abstract][Full Text] [Related]
35.
Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J
Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
[No Abstract] [Full Text] [Related]
36. Clinical and biological prognostic factors in follicular lymphoma patients.
Jóna Á; Kenyeres A; Barna S; Illés Á; Simon Z
PLoS One; 2022; 17(8):e0272787. PubMed ID: 35925993
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis.
Kim YJ; Han S; Kim YS; Nam JH
J Gynecol Oncol; 2019 Sep; 30(5):e66. PubMed ID: 31328452
[TBL] [Abstract][Full Text] [Related]
38. F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study.
Gallicchio R; Nardelli A; Calice G; Guarini A; Guglielmi G; Storto G
Eur J Radiol; 2021 Mar; 136():109564. PubMed ID: 33517249
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
Zamagni E; Patriarca F; Nanni C; Zannetti B; Englaro E; Pezzi A; Tacchetti P; Buttignol S; Perrone G; Brioli A; Pantani L; Terragna C; Carobolante F; Baccarani M; Fanin R; Fanti S; Cavo M
Blood; 2011 Dec; 118(23):5989-95. PubMed ID: 21900189
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of
Ahn SY; Park HK; Moon JH; Baek DW; Cho HJ; Sohn SK; Kang SR; Min JJ; Bom HS; Hong CM; Jeong SY; Song GY; Yang DH; Ahn JS; Kim HJ; Jung SH; Lee JJ
Int J Hematol; 2021 May; 113(5):668-674. PubMed ID: 33475961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]